Hard end points are needed for intensive glycaemic control in patients with type 2 diabetes
BMJ
.
2012 Jan 31:344:e708; author reply e710.
doi: 10.1136/bmj.e708.
Authors
John S Yudkin
,
Kasia J Lipska
PMID:
22293372
DOI:
10.1136/bmj.e708
No abstract available
Publication types
Letter
Comment
MeSH terms
Blood Glucose*
Cardiovascular Diseases / mortality*
Diabetes Mellitus, Type 2 / mortality*
Diabetes Mellitus, Type 2 / prevention & control*
Diabetic Angiopathies / mortality*
Humans
Substances
Blood Glucose